Cargando…
A novel SRSF3 inhibitor, SFI003, exerts anticancer activity against colorectal cancer by modulating the SRSF3/DHCR24/ROS axis
As the modulation of serine/arginine-rich splicing factor 3 (SRSF3) may be therapeutically beneficial to colorectal cancer (CRC) treatment, the identification of novel SRSF3 inhibitors is highly anticipated. However, pharmaceutical agents targeting SRSF3 have not yet been discovered. Here, we propos...
Autores principales: | Zhang, Yawen, Wang, Mengmeng, Meng, Fanyi, Yang, Man, Chen, Yinshuang, Guo, Xuqin, Wang, Weiwei, Zhu, Yifan, Guo, Yundi, Feng, Chunlai, Tian, Shen, Zhang, Hongjian, Li, Huanqiu, Sun, Jing, Wang, Weipeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9061822/ https://www.ncbi.nlm.nih.gov/pubmed/35501301 http://dx.doi.org/10.1038/s41420-022-01039-9 |
Ejemplares similares
-
SRSF3 Promotes Angiogenesis in Colorectal Cancer by Splicing SRF
por: Chen, Yinshuang, et al.
Publicado: (2022) -
Biological function and molecular mechanism of SRSF3 in cancer and beyond
por: Xiong, Jian, et al.
Publicado: (2022) -
SRSF7 and SRSF3 depend on RNA sequencing motifs and secondary structures to regulate Microprocessor
por: Le, Minh Ngoc, et al.
Publicado: (2023) -
Oncogenic SRSF3 in health and diseases
por: Jia, Rong, et al.
Publicado: (2023) -
Regulation of Mcl-1 by SRSF1 and SRSF5 in Cancer Cells
por: Gautrey, Hannah L., et al.
Publicado: (2012)